secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001104659-23-102314
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel launches NexoBrid in U.S. for severe thermal burns; $300M addressable market
--------------------------------------------------------------------------------

- Full commercial launch of NexoBrid for eschar removal in adults with deep partial/full-thickness thermal burns.
- Selective enzymatic debridement preserves viable tissue vs. surgical excision.
- Addressable U.S. market of ~30,000 patients/year, equating to $300 million.
- Product can be applied in up to two 4-hour sessions covering up to 20% total body surface area.
- Launch expands Vericel's Burn Care franchise and diversifies revenue stream.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000110465923102314/0001104659-23-102314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000110465923102314/tm2326562d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-102314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer